Literature DB >> 7769099

KCl cotransport activity in light versus dense transferrin receptor-positive sickle reticulocytes.

R S Franco1, M Palascak, H Thompson, C H Joiner.   

Abstract

A subset of sickle cells becomes K(+)-depleted and dehydrated before or soon after leaving the bone marrow. These young cells may be identified in blood as transferrin receptor-positive (TfR+) dense reticulocytes. KCl cotransport, which is normally active in young erythroid cells with a maximum at pH 6.8, is a candidate pathway for K+ depletion of sickle reticulocytes. In this investigation, KCl cotransport activity was evaluated in young, TfR+ cells which had become dense in vivo and in age-matched cells which had retained normal hydration. Sickle erythrocytes were first separated into three primary density fractions, with care taken to preserve the in vivo hydration state. After normalization of intracellular hemoglobin concentration with nystatin, the cells were incubated at 37 degrees C for 20 min at pH 6.8 and 7.4. Before and after incubation, each primary fraction was separated into four secondary density fractions. The percentage of TfR+ cells in each secondary fraction was measured and a density distribution for TfR+ cells was determined for each primary fraction before and after incubation. The density shift during incubation was a measure of KCl cotransport. TfR+ cells from the denser primary fractions II and III had significantly more density shift than TfR+ cells from the light fraction I. Although the shifts were larger at low pH, differences between primary fractions were also observed at pH 7.4. These data indicate that the cells which become dense quickly in vivo have more KCl cotransport activity than those which remain light in vivo, and support this pathway as a primary mechanism for dehydration of young sickle cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769099      PMCID: PMC295939          DOI: 10.1172/JCI117958

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Cation depletion by the sodium pump in red cells with pathologic cation leaks. Sickle cells and xerocytes.

Authors:  C H Joiner; O S Platt; S E Lux
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

2.  Fetal hemoglobin and potassium in isolated transferrin receptor-positive dense sickle reticulocytes.

Authors:  R S Franco; R Barker-Gear; M A Miller; S M Williams; C H Joiner; D L Rucknagel
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

3.  Volume-dependent and NEM-stimulated K+,Cl- transport is elevated in oxygenated SS, SC and CC human red cells.

Authors:  M Canessa; A Spalvins; R L Nagel
Journal:  FEBS Lett       Date:  1986-05-05       Impact factor: 4.124

4.  Separation of erythrocytes according to age on a simplified density gradient.

Authors:  L M Corash; S Piomelli; H C Chen; C Seaman; E Gross
Journal:  J Lab Clin Med       Date:  1974-07

5.  Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia.

Authors:  J F Bertles; P F Milner
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

6.  Regulation of erythrocyte cation and water content in sickle cell anemia.

Authors:  C Brugnara; H F Bunn; D C Tosteson
Journal:  Science       Date:  1986-04-18       Impact factor: 47.728

7.  Stabilization of the shape of sickled cells by calcium and A23187.

Authors:  M R Clark; A C Greenquist; S B Shohet
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

8.  Requirement for therapeutic inhibition of sickle haemoglobin gelation.

Authors:  H R Sunshine; J Hofrichter; W A Eaton
Journal:  Nature       Date:  1978-09-21       Impact factor: 49.962

9.  Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.

Authors:  G M Brittenham; A N Schechter; C T Noguchi
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

10.  Ionic and osmotic equilibria of human red blood cells treated with nystatin.

Authors:  J C Freedman; J F Hoffman
Journal:  J Gen Physiol       Date:  1979-08       Impact factor: 4.086

View more
  8 in total

1.  Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.

Authors:  L De Franceschi; D Bachir; F Galacteros; G Tchernia; T Cynober; S Alper; O Platt; Y Beuzard; C Brugnara
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells.

Authors:  R S Franco; J Lohmann; E B Silberstein; G Mayfield-Pratt; M Palascak; T A Nemeth; C H Joiner; M Weiner; D L Rucknagel
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

Review 3.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

4.  K-Cl cotransporter gene expression during human and murine erythroid differentiation.

Authors:  Dao Pan; Theodosia A Kalfa; Daren Wang; Mary Risinger; Scott Crable; Anna Ottlinger; Sharat Chandra; David B Mount; Christian A Hübner; Robert S Franco; Clinton H Joiner
Journal:  J Biol Chem       Date:  2011-07-06       Impact factor: 5.157

5.  Regulation of K-Cl cotransport by protein phosphatase 1alpha in mouse erythrocytes.

Authors:  Lucia De Franceschi; Emma Villa-Moruzzi; Andrea Biondani; Angela Siciliano; Carlo Brugnara; Seth L Alper; Clifford A Lowell; Giorgio Berton
Journal:  Pflugers Arch       Date:  2005-11-11       Impact factor: 3.657

6.  Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells.

Authors:  P Merciris; W J Claussen; C H Joiner; F Giraud
Journal:  Pflugers Arch       Date:  2003-03-21       Impact factor: 3.657

7.  Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.

Authors:  C Brugnara; B Gee; C C Armsby; S Kurth; M Sakamoto; N Rifai; S L Alper; O S Platt
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

8.  The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype).

Authors:  A Hannemann; E Weiss; D C Rees; S Dalibalta; J C Ellory; J S Gibson
Journal:  Anemia       Date:  2010-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.